National Health Investors Stock Book Value Per Share
| WX6 Stock | EUR 69.00 1.00 1.43% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
National |
National Health Investors Company Book Value Per Share Analysis
National Health's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current National Health Book Value Per Share | 29.27 X |
Most of National Health's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of National Health Investors is about 29.275 times. This is 53.35% higher than that of the Real Estate sector and 62.46% higher than that of the REIT - Healthcare Facilities industry. The book value per share for all Germany stocks is 98.48% higher than that of the company.
National Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in book value per share category among its peers.
National Fundamentals
| Return On Equity | 0.0467 | |||
| Return On Asset | 0.0336 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.52 % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 43.39 M | |||
| Shares Owned By Insiders | 4.77 % | |||
| Shares Owned By Institutions | 63.16 % | |||
| Price To Earning | 19.80 X | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 8.22 X | |||
| Revenue | 278.19 M | |||
| Gross Profit | 268.98 M | |||
| EBITDA | 178.82 M | |||
| Net Income | 66.4 M | |||
| Cash And Equivalents | 5.74 M | |||
| Cash Per Share | 0.13 X | |||
| Total Debt | 1.15 B | |||
| Debt To Equity | 91.00 % | |||
| Current Ratio | 2.21 X | |||
| Book Value Per Share | 29.27 X | |||
| Cash Flow From Operations | 185.34 M | |||
| Earnings Per Share | 1.41 X | |||
| Target Price | 69.14 | |||
| Number Of Employees | 25 | |||
| Beta | 0.94 | |||
| Market Capitalization | 2.28 B | |||
| Total Asset | 2.51 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.07 % | |||
| Net Asset | 2.51 B | |||
| Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in National Stock
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.